Opinion|Videos|August 16, 2024
Personalizing Treatment Selection
A key opinion leader in dermatology explains how the presence of type 2 inflammation informs their treatment decisions for atopic dermatitis and prurigo nodularis, while also detailing additional patient-specific factors such as age, comorbidities, and disease severity that influence their therapeutic approach.
Advertisement
Episodes in this series
- How does knowing that type 2 inflammation is a cause influence your treatment selection?
- Beyond identifying the underlying cause, what other patient-specific factors (e.g., age, comorbidities, disease severity) do you consider when selecting treatment regimens for AD or PN?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma
2
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
3
Health Equity & Access Weekly Roundup: June 26, 2026
4
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer
5